Compare Nusantara Infrastructure Tbk. (META) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nusantara Infrastructure Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Nusantara Infrastructure Tbk. trades at Rp238 (market cap 4.22T), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Nusantara Infrastructure Tbk. is far larger — about 40.4× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| META | SCPI | |
|---|---|---|
Market Cap | 4.22T | 104.4B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nusantara Infrastructure Tbk.
PT Nusantara Infrastructure Tbk (the Company) was established in Jakarta based on Notarial Deed No.3 dated September 1, 1995 of Abdullah Ashal SH., under the name of PT Sawitia Bersama Darma.
Read more on META →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
